MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Exploring hospitalizations and visits to the emergency room of patients with Parkinson’s disease: A ten years’ follow-up

    M.T. Montojo, Y. Macias, M. ÁLvarez, C. Martín, L. Borrega, L. Vela (Alcorcón, Spain)

    Objective: To describe the number and reasons of the visits to the emergency room (ER) and the hospitalizations of Parkinson's disease (PD) patients for a…
  • 2016 International Congress

    The differentiated treatment of Parkinson’s disease in patients with concomitant diabetes mellitus(DM) type 2

    F.S. Akhmedova, M.K.U. Tukhtamishev (Tashkent, Uzbekistan)

    Objective: To study the state of lipid metabolism in PD patients with concomitant type 2 diabetes with different glucose tolerance and the influence of the…
  • 2016 International Congress

    Development of a nanoherbaceutical containing natural L-DOPA from mucuna pruriens for the prevention and treatment of Parkinson’s disease in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine induced animal model

    P.C. Bhatt, V. Kumar (New Delhi, India)

    Objective: To prepare and evaluate the nanoherbaceutical formulation containing natural L-DOPA from Mucuna pruriens against the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) induced Parkinson's disease (PD). Background: PD is…
  • 2016 International Congress

    The role of proprioceptive deficits as a mechanism of gait impairments in postural instability and gait disorder Parkinson’s disease subtype

    M.P. Pereira, P.H.S. Pelicioni, Q.J. Almeida, L.T.B. Gobbi (Leuven, Belgium)

    Objective: To evaluate the role of proprioceptive processing on the gait parameters of different subtypes of Parkinson's disease. Background: Two major subtypes are considered in…
  • 2016 International Congress

    Duration of levodopa treatment and prevalence of osteoporosis in patients with Parkinson’s disease

    S.H. Guptha (Peterborough, United Kingdom)

    Objective: To assess whether the prevalence of osteoporosis increases with the duration of levodopa treatment in patients with Parkinson's disease. Background: Patients with Parkinson's disease…
  • 2016 International Congress

    Predictive validity of statistical models of Parkinson’s disease progression

    A. Mendes, A. Gonçalves, N. Vila-Chã, M. Calejo, I. Moreira, J. Fernandes, J. Damásio, A. Bastos-Lima, S. Cavaco (Porto, Portugal)

    Objective: To develop statistical models of Parkinson's disease (PD) progression based on a transversal assessment and to explore its predictive value in a three-year follow-up.…
  • 2016 International Congress

    Effects of movement rate and amplitude on repetitive finger motion in people with Parkinson’s disease and freezing of gait

    M.P. Pereira, S. Vercruysse, E. Heremans, A. Nieuwboer (Leuven, Belgium)

    Objective: To evaluate the role of movement amplitude and rate on spatiotemporal parameters and EMG response during a rhythmic and continuous finger-tapping paradigm in people…
  • 2016 International Congress

    European physiotherapy guideline for Parkinson’s disease: Information for neurologists

    D.L.M. Radder, M.J. Faber, N.M. de Vries, B.R. Bloem, S.H.J. Keus (Nijmegen, Netherlands)

    Objective: We aim to inform physicians on the value of physiotherapy (PT) for people with Parkinson's disease (PwP) and on opportunities to optimize referral to…
  • 2016 International Congress

    A comparison of standards of care in Parkinson’s disease between a general neurology clinic and a specialist movement disorders clinic based on the UK NICE guidelines

    S.M. Yap, M.O. Dablouk, S. O'Sullivan (Dublin, Ireland)

    Objective: To compare standards of care for patients with Parkinson's disease (PD) between a general neurology clinic and specialist movement disorders clinic based on the…
  • 2016 International Congress

    A heterozygous splicing mutation c.823-10G>T at the intron9/exon 10 of the MAPT gene in an Irish family with FTDP- 17

    E.M. Fallon, D.A. Olszewska, C. McGuigan, I. Delon, F. Brett, B. Lawlor, M. Hutchinson, M. Hutton, T. Lynch (Dublin, Ireland)

    Objective: *Authors EMF and DAO contributed equally. To describe the phenotype of the second reported pedigree with the heterozygous splicing mutation c.823-10G>T at the intron…
  • « Previous Page
  • 1
  • …
  • 1519
  • 1520
  • 1521
  • 1522
  • 1523
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • The hardest symptoms that bother patients with Parkinson's disease
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Welcome to the MDS Abstracts Site
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley